Condition | Pathway | # of genes | p-value | Benjamini corrected p-value |
---|---|---|---|---|
Heart 48 h - Injured | Biosynthesis of antibiotics | 62 | < 0.001 | < 0.001 |
Metabolic pathways | 237 | < 0.001 | < 0.001 | |
Insulin resistance | 36 | < 0.001 | < 0.001 | |
cGMP-PKG signaling pathway | 48 | < 0.001 | < 0.001 | |
Fatty acid metabolism | 23 | < 0.001 | < 0.001 | |
PI3K-Akt signaling pathway | 78 | < 0.001 | < 0.001 | |
Leukocyte transendothelial migration | 37 | < 0.001 | < 0.001 | |
Carbon metabolism | 37 | < 0.001 | < 0.001 | |
Citrate cycle (TCA cycle) | 16 | < 0.001 | < 0.001 | |
Focal adhesion | 53 | < 0.001 | < 0.001 | |
Arrhythmogenic right ventricular cardiomyopathy (ARVC) | 23 | < 0.001 | 0.001 | |
PPAR signaling pathway | 23 | < 0.001 | 0.004 | |
Protein digestion and absorption | 25 | < 0.001 | 0.005 | |
Hypertrophic cardiomyopathy (HCM) | 23 | 0.001 | 0.006 | |
Dilated cardiomyopathy | 22 | 0.003 | 0.021 | |
Liver Tc,max | Endocytosis | 4 | 0.016 | 0.537 |
Kidney 48 h - Injured | Complement and coagulation cascades | 14 | < 0.001 | < 0.001 |
Cell cycle | 16 | < 0.001 | < 0.001 | |
p53 signaling pathway | 9 | < 0.001 | 0.003 | |
Bile secretion | 9 | < 0.001 | 0.003 | |
PPAR signaling pathway | 9 | < 0.001 | 0.004 | |
FoxO signaling pathway | 10 | 0.001 | 0.037 | |
Progesterone-mediated oocyte maturation | 8 | 0.001 | 0.043 | |
MicroRNAs in cancer | 9 | 0.006 | 0.141 | |
Small cell lung cancer | 7 | 0.006 | 0.133 | |
Carbohydrate digestion and absorption | 5 | 0.007 | 0.145 | |
Biosynthesis of unsaturated fatty acids | 4 | 0.017 | 0.265 | |
Lung Tc,max | TNF signaling pathway | 4 | 0.026 | 0.974 |
Pathways in cancer | 7 | 0.029 | 0.863 | |
NOD-like receptor signaling pathway | 3 | 0.043 | 0.866 | |
Lung 48 h - Injured | Calcium signaling pathway | 8 | 0.001 | 0.145 |
PPAR signaling pathway | 5 | 0.005 | 0.266 | |
Oocyte meiosis | 5 | 0.016 | 0.499 | |
p53 signaling pathway | 4 | 0.024 | 0.548 | |
Signaling pathways regulating pluripotency of stem cells | 5 | 0.035 | 0.610 | |
Protein digestion and absorption | 4 | 0.044 | 0.627 | |
Neuroactive ligand-receptor interaction | 7 | 0.044 | 0.571 | |
Tyrosine metabolism | 3 | 0.047 | 0.542 |